FDA Warns Medical Food Co. Amid Continuing Crackdown

Law360, New York (January 21, 2014, 5:43 PM EST) -- The U.S. Food and Drug Administration on Tuesday released a new warning letter accusing California-based NVN Therapeutics of illegally selling a prescription drug under the guise of so-called medical foods, continuing a sudden crackdown on the niche nutritional products.

In the warning letter, regulators took issue with a product called Glucorein PCOS, which is promoted to alleviate a common disorder known as polycystic ovary syndrome.

The product’s active ingredients are chlorogenic acid and L-cysteine, but such is irrelevant because “there are no distinctive nutritional requirements ......
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.